Article
GLT8D2 is a prognostic biomarker and regulator of immune cell infiltration in gastric cancer
22 May 2024
Abstract excerpt
Because of the considerable tumor heterogeneity in gastric cancer (GC), only a limited group of patients experiences positive outcomes from immunotherapy. Herein, we aim to develop predictive models related to glycosylation genes to provide a more comprehensive understanding of immunotherapy for GC. RNA sequencing (RNA-seq) data and corresponding clinical outcomes were obtained from GEO and TCGA databases, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
